What is the recommended levofloxacin dosage and duration for treating uncomplicated typhoid fever in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levofloxacin Dosing for Typhoid Fever

For uncomplicated typhoid fever, levofloxacin should be dosed at 500-750 mg once daily orally for 7-10 days in adults, and 8 mg/kg every 12 hours (maximum 250 mg per dose) in children aged 6 months to 17 years. However, this recommendation comes with critical caveats regarding resistance patterns.

Adult Dosing

The WHO Pocket Book of Hospital Care recommends ciprofloxacin 15 mg/kg twice daily for 7-10 days as first-line treatment for typhoid in children 1. While this guideline specifically addresses ciprofloxacin rather than levofloxacin, the fluoroquinolone class recommendation is relevant.

For levofloxacin specifically:

  • 500 mg once daily orally for 7 days demonstrated 100% clinical efficacy in a study of 30 patients with uncomplicated typhoid fever 2
  • 750 mg once daily orally for 7 days was also shown to be effective, safe, and well-tolerated in adult patients 3, 4

The FDA label supports 500 mg once daily dosing for various infections, with pharmacokinetic data showing adequate plasma concentrations for bacterial eradication 5.

Pediatric Dosing

For children aged 6 months to 17 years: 8 mg/kg every 12 hours orally or IV (maximum 250 mg per dose) 6. This dosing achieves comparable steady-state plasma exposures to adults receiving 500 mg once daily 5.

Weight-based adjustments:

  • Children <50 kg: 8 mg/kg every 12 hours (maximum 250 mg/dose)
  • Children ≥50 kg: 500-750 mg every 24 hours 6

Treatment Duration

7-10 days is the recommended duration 1, 3, 2. The 7-day regimen appears adequate for uncomplicated cases, with studies showing excellent clinical response and no relapses 2.

Critical Resistance Considerations

This recommendation requires immediate modification based on local resistance patterns, particularly for infections acquired in South Asia:

  • Fluoroquinolone resistance is now common in South Asia, especially Pakistan, where extensively drug-resistant (XDR) typhoid has emerged 7, 8, 9
  • If fluoroquinolone resistance exceeds 10% locally, ceftriaxone 80 mg/kg daily (maximum 2-4 g) for 5-7 days or azithromycin 20 mg/kg daily (maximum 1 g) for 5-7 days should be used instead 1, 10
  • For XDR typhoid from Pakistan, levofloxacin is likely ineffective 7, 8

Comparative Effectiveness

Recent evidence suggests:

  • Azithromycin may be superior to fluoroquinolones for uncomplicated enteric fever, with lower clinical failure rates (OR 0.48) and fewer relapses (OR 0.09) 10
  • Ceftriaxone performs comparably to azithromycin with possibly faster fever clearance (0.52 days shorter) 11
  • Cefixime appears inferior to fluoroquinolones with higher failure rates (RR 13.39) 11

Practical Algorithm

  1. Determine travel history/acquisition location

    • South Asia (especially Pakistan): Avoid fluoroquinolones → Use ceftriaxone or azithromycin
    • Other endemic areas: Check local resistance data
  2. If fluoroquinolone appropriate:

    • Adults: Levofloxacin 500-750 mg once daily × 7-10 days
    • Children: Levofloxacin 8 mg/kg every 12 hours (max 250 mg/dose) × 7-10 days
  3. If fluoroquinolone resistance suspected/confirmed:

    • First choice: Azithromycin 20 mg/kg daily (max 1 g) × 5-7 days
    • Alternative: Ceftriaxone 80 mg/kg daily (max 2-4 g) IV × 5-7 days

Important Caveats

  • Obtain blood cultures before starting treatment to guide therapy based on susceptibilities 10, 8
  • Monitor for musculoskeletal adverse effects in children, as fluoroquinolones carry concerns about cartilage effects 12, 5
  • The 750 mg dose may offer no additional benefit over 500 mg for uncomplicated cases but increases cost
  • Clinical response (defervescence) typically occurs within 2-3 days; lack of response by day 5 suggests resistance 2

References

Research

Open study on efficacy and safety of levofloxacin in treatment of uncomplicated typhoid fever.

The Southeast Asian journal of tropical medicine and public health, 2006

Research

Effectiveness of levofloxacin in enteric fever.

Mymensingh medical journal : MMJ, 2011

Research

Levofloxacin in enteric fever--a study.

Journal of the Indian Medical Association, 2005

Research

Enteric (typhoid and paratyphoid) fever.

Lancet (London, England), 2025

Research

How multidrug resistance in typhoid fever affects treatment options.

Annals of the New York Academy of Sciences, 2014

Research

Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.

The Cochrane database of systematic reviews, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.